Research & Development News Channel

Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19

A new modelling study conducted in a simulated Singapore setting has estimated that a combined approach of physical distancing [2] interventions, comprising quarantine (for infected individuals and their families), school closure, and workplace distancing, is most effective at reducing the number of SARS-CoV-2 cases compared with other intervention scenarios included in the study.

CAR macrophages go beyond T cells to fight solid tumors

Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors. Now researchers from the Perelman School of Medicine at the University of Pennsylvania may have an alternative to T cell therapy that can overcome those challenges.

Vivli to launch a portal for sharing data from COVID-19 trials

In a visible sign of data sharing leadership, Vivli, the Center for Clinical Research Data has committed to serving the open science community through the launch of a COVID-19 portal for sharing of completed interventional treatment trial data. All member and user fees would be waived for sharing and access.

Understanding how COVID-19 affects children vital to slowing pandemic

Though COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately, limit the disease's spread and ensure the youngest patients get the care they need.

Favipiravir flu drug 'clearly effective' in treating COVID-19

According to the multiple news articles the drug favipiravir (sold under the brand name Avigan), developed by Fujifilm Toyama Chemical, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.

The COVID-19 coronavirus epidemic has a natural origin

The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic and spread to more than 70 other countries is the product of natural evolution, according to findings published today in the journal Nature Medicine.

COVID-19: The immune system can fight back

Melbourne researchers have mapped immune responses from one of Australia's first novel coronavirus (COVID-19) patients, showing the body's ability to fight the virus and recover from the infection.

Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) - a joint venture between the University of Melbourne and the Royal Melbourne hospital

Research & Development News

Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19

CAR macrophages go beyond T cells to fight solid tumors

Vivli to launch a portal for sharing data from COVID-19 trials

Understanding how COVID-19 affects children vital to slowing pandemic

Favipiravir flu drug 'clearly effective' in treating COVID-19

The COVID-19 coronavirus epidemic has a natural origin

COVID-19: The immune system can fight back

More Pharma News ...

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs